Metabolic medicines
SLU-PP-332
An experimental estrogen-related receptor agonist with cell and mouse findings, not established human exercise benefits.
Cell and mouse experiments
Practical use
Reviewed practical notes
- Identify the target correctly
- ERR means estrogen-related receptor, not estrogen receptor.
- Keep species visible
- Mouse fat and endurance results are not human treatment outcomes.
- Avoid replacement claims
- Changing one metabolic pathway does not reproduce all effects of exercise.
Overview
SLU-PP-332 is a small-molecule research compound targeting estrogen-related receptors (ERRs). These nuclear receptors participate in metabolic gene regulation. Their name should not be confused with estrogen receptors or interpreted as proof that the compound acts like estrogen.
Risks and limitations
The reviewed studies do not establish human safety, clinical effectiveness or the identity of commercial products using this name. An increase in energy expenditure in a mouse does not show that the same intervention is tolerable or beneficial in people.
How to read this
The research provides a biological rationale for further experiments. It does not establish that a compound can replace the cardiovascular, musculoskeletal and behavioral effects of exercise. No controlled human performance trial is provided by these sources.
Research explained
Receptor activity and muscle-related experiments
Who was studied
Cell systems and mice used to investigate ERR activation and oxidative muscle function.
What was found
The compound activated ERR subtypes, with stronger potency at ERR-alpha, and was associated with oxidative muscle changes and increased mouse endurance.
What it cannot establish
Target activity, gene expression and animal endurance do not establish human fitness or safe exposure. The evidence is preclinical.
Read the original studyMouse metabolic-syndrome models
Who was studied
Diet-induced obese mice and leptin-deficient ob/ob mice.
What was found
Researchers reported higher energy expenditure and fatty-acid oxidation, less fat accumulation and improved insulin sensitivity in the studied models.
What it cannot establish
Genetic and diet-induced mouse obesity are models, not human clinical populations. The study does not establish long-term human benefit or harm rates.
Read the original studyA model is a test of a hypothesis
The mouse findings connect receptor signaling with metabolic outcomes under controlled conditions. Translation still requires human studies that measure clinically meaningful outcomes, adverse effects and durability.
Supporting sourceSources
Sources checked 2026-10-01.
General education; not a personal treatment plan.